Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $558M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 446,980 | $30.86M | 5.5% | $48.11 | +49.7% | COM PAR $.01 | 457669307 |
| — | VERONA PHARMA PLC | 641,901 | $29.81M | 5.3% | $30.67 | — | SPONSORED ADS | 925050106 |
| XENE | XENON PHARMACEUTICALS INC | 684,986 | $26.85M | 4.8% | $38.49 | +7.4% | COM | 98420N105 |
| ARGX | ARGENX SE | 43,078 | $26.49M | 4.7% | $380.43 | — | SPONSORED ADR | 04016X101 |
| — | INTRA-CELLULAR THERAPIES INC | 294,414 | $24.59M | 4.4% | $72.12 | — | COM | 46116X101 |
| NUVL | NUVALENT INC | 309,521 | $24.23M | 4.3% | $68.62 | +36.1% | COM | 670703107 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 453,376 | $23.18M | 4.2% | $48.33 | +15.7% | COM | 22663K107 |
| PCVX | VAXCYTE INC | 276,905 | $22.67M | 4.1% | $63.04 | +57.5% | COM | 92243G108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 506,908 | $20.96M | 3.8% | $29.91 | +39.3% | COM | 604749101 |
| JANX | JANUX THERAPEUTICS INC | 383,602 | $20.54M | 3.7% | $52.89 | 0.0% | COM | 47103J105 |
| VERA | VERA THERAPEUTICS INC | 464,807 | $19.66M | 3.5% | $39.59 | +11.8% | CL A | 92337R101 |
| ISRG | INTUITIVE SURGICAL INC | 35,032 | $18.29M | 3.3% | $415.00 | +25.5% | COM NEW | 46120E602 |
| RVMD | REVOLUTION MEDICINES INC | 403,915 | $17.67M | 3.2% | $50.47 | 0.0% | COM | 76155X100 |
| EXAS | EXACT SCIENCES CORP | 309,890 | $17.41M | 3.1% | $62.23 | 0.0% | COM | 30063P105 |
| AXSM | AXSOME THERAPEUTICS INC | 192,146 | $16.26M | 2.9% | $69.19 | +32.9% | COM | 05464T104 |
| NTRA | NATERA INC | 99,159 | $15.7M | 2.8% | $114.81 | +26.9% | COM | 632307104 |
| GKOS | GLAUKOS CORP | 96,097 | $14.41M | 2.6% | $124.44 | +10.7% | COM | 377322102 |
| GERN | GERON CORP | 3,893,327 | $13.78M | 2.5% | $4.44 | -10.0% | COM | 374163103 |
| BBIO | BRIDGEBIO PHARMA INC | 452,290 | $12.41M | 2.2% | $26.21 | -1.4% | COM | 10806X102 |
| ASND | ASCENDIS PHARMA A/S | 87,804 | $12.09M | 2.2% | $127.91 | — | SPONSORED ADR | 04351P101 |
| HQY | HEALTHEQUITY INC | 125,867 | $12.08M | 2.2% | $93.19 | 0.0% | COM | 42226A107 |
| ELVN | ENLIVEN THERAPEUTICS INC | 535,092 | $12.04M | 2.2% | $21.53 | +20.4% | COM | 29337E102 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 947,878 | $12.01M | 2.2% | $14.27 | -2.5% | COM | 23954D109 |
| — | MERUS N V | 285,159 | $11.99M | 2.1% | $59.17 | — | COM | N5749R100 |
| ADMA | ADMA BIOLOGICS INC | 684,230 | $11.73M | 2.1% | $15.64 | +20.3% | COM | 000899104 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,451,037 | $11.71M | 2.1% | $11.07 | -17.1% | COM | 68622P109 |
| ACLX | ARCELLX INC | 152,356 | $11.68M | 2.1% | $66.59 | +29.7% | COMMON STOCK | 03940C100 |
| APGE | APOGEE THERAPEUTICS INC | 252,725 | $11.45M | 2.1% | $51.00 | 0.0% | COM | 03770N101 |
| HROW | HARROW INC | 304,874 | $10.23M | 1.8% | $33.81 | +30.9% | COM | 415858109 |
| BHVN | BIOHAVEN LTD | 262,442 | $9.802M | 1.8% | $31.10 | +50.0% | COM | G1110E107 |
| CRMD | CORMEDIX INC | 1,021,421 | $8.274M | 1.5% | $9.99 | 0.0% | COM | 21900C308 |
| SPRY | ARS PHARMACEUTICALS INC | 593,291 | $6.259M | 1.1% | $11.89 | +17.8% | COM | 82835W108 |
| BCAX | BICARA THERAPEUTICS INC | 346,170 | $6.03M | 1.1% | $25.50 | -18.4% | COM | 055477103 |
| — | BLUEPRINT MEDICINES CORP | 67,143 | $5.856M | 1.0% | $107.78 | — | COM | 09627Y109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 441,587 | $5.838M | 1.0% | $20.80 | -17.7% | COM | 87164F105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 45,536 | $3.504M | 0.6% | $72.36 | 0.0% | COM NEW | 74006W207 |